Human Mesenchymal Stem Cells Exploit the Immune Response Mediating Chemokines to Impact the Phenotype of Glioblastoma

In contrast to the application of human mesenchymal stem cells (hMSCs) in regenerative medicine, only a limited number of studies are addressing their use in anticancer therapy. As the latter may represent a new hope to improve the survival of patients with glioblastoma multiformae (GBM), the most c...

Full description

Bibliographic Details

Published in:	Cell Transplantation
Main Authors:	Helena Motaln, Kristina Gruden, Matjaž Hren, Christian Schichor, Monika Primon, Ana Rotter, Tamara T. Lah
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-07-01
Online Access:	https://doi.org/10.3727/096368912X640547